Favourites   Have ideas?  Sign in / Register

Positive:   Acquisitions/Investing ↓12.53   Security ↓2.46   Technology ↓2.46 «See more»   Country: Australia ↑9.83   Animals ↑45.43   Pets ↑45.43

Negative:   Bad infrastructure  ↓4.93


Biotechnology segment

ACOR Acorda Therapeutics, Inc. - Common Stock 8.75% 8.75% 0 + Disease: Neurology/Alzheimer/Parkinson's, Medicine, Biotechnology


Last highlighted: Form 8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain.. $ACOR https://t.co/pzylSpmKBK
+ My List
APTO Aptose Biosciences, Inc. - Common Shares 6.53% down 7.56% -1.03 + Biotechnology

+ My List
APVO Aptevo Therapeutics Inc. - Common Stock 6.47% down 8.18% -1.71 + Biotechnology, Medicine, Disease: Oncology, Immunology


Last highlighted: $APVTW [15s. delayed] filed form 8-K on May 27, 09:02:28: Item7.01: Regulation FD https://t.co/MpE2r05xab
+ My List
BNTC Benitec Biopharma Inc. - Common Stock 2.94% down 13.37% -10.43 + Biopharma, Biotechnology, RNA, Medicine, Gene and cell


Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q
+ My List
BNTX BioNTech SE - American Depositary Shares 3.06% down 11.04% -7.98 + Biotechnology, Immunology, Covid (fighting), Medicine


Last highlighted: #BNTX SEC report: BioNTech SE Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BioNTech SE -- SEC File Number 211142358
+ My List
CYCC Cyclacel Pharmaceuticals, Inc. - Common Stock -4.93% down 9.09% -14.02 + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
+ My List
DARE Dare Bioscience, Inc. - Common Stock 1.81% 1.81% 0 + Biotechnology, Healthcare, Women Health


Last highlighted: SEC Form 8-K [Press/News Current Report] filed by $DARE Dare Bioscience, Inc. https://t.co/iSB0Q2Ucpd
+ My List
ENTX Entera Bio Ltd. - Ordinary Shares 1.74% 1.74% 0 + Country: Israel, Biotechnology, Pharmaceutical


Last highlighted: $ENTX 📜 SEC Form 6-K filed by Entera Bio Ltd. https://t.co/dws8IKVGAV #healthcare
+ My List
ENTXW Entera Bio Ltd. - Warrant up -10.78% 10.78 + Country: Israel, Biotechnology, Pharmaceutical

+ My List
FBIO Fortress Biotech, Inc. - Common Stock 6.9% down 7.59% -0.69 + Pharmaceutical , Biopharma, Biotechnology, Medicine

+ My List
FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock -0.43% -0.43% 0 + Medicine, Biotechnology, Biopharma

+ My List
FLDM Fluidigm Corporation - Common Stock 6.42% down 7.82% -1.4 + Life Sciences, Biology, Cancer fight, Biotechnology, RNA


Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270
+ My List
FRLN Freeline Therapeutics Holdings plc - ADSs 2.91% down 7.67% -4.76 + Medicine, Biotechnology, Gene and cell

+ My List
GLYC GlycoMimetics, Inc. - Common Stock 0.85% down 7.73% -6.88 + Biotechnology, Medicine, Disease: Leukemia

+ My List
IGMS IGM Biosciences, Inc. - Common Stock -7.01% up -7.33% 0.32 + Biotechnology, Gene and cell, Medicine


Last highlighted: #IGMS SEC report: IGM Biosciences, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IGM Biosciences, Inc. -- SEC File Number
+ My List
IMNM Immunome, Inc. - Common Stock 12.2% 12.2% 0 + Cancer fight, Biotechnology, Medicine, Immunology

+ My List
IMRN Immuron Limited - American Depositary Shares 9.83% 9.83% 0 + Biotechnology, Country: Australia, Biopharma, Medicine


Last highlighted: $IMRN 📜 SEC Form 6-K filed by Immuron Limited https://t.co/xsrBOQcQ0a
+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock -0.67% down 10.03% -10.7 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
KIN Kindred Biosciences, Inc. - Common Stock 45.43% down 45.74% -0.31 + Animals, Biopharma, Biotechnology, Medicine, Pets


Last highlighted: #KIN SEC report: Kindred Biosciences, Inc. Definitive proxy statement relating to merger or acquisition
SEC Filing Form DEFM14A filed by Kindred Biosciences, Inc. -- SEC File Number 211102924
+ My List
LRMR Larimar Therapeutics, Inc. - Common Stock -8.79% -8.79% 0 + Medicine, Gene and cell, Biotechnology

+ My List
MBRX Moleculin Biotech, Inc. - Common Stock 6.57% down 7.14% -0.57 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious


Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities
+ My List
MCRB Seres Therapeutics, Inc. - Common Stock 1.24% down 13.87% -12.63 + Medicine, Microbiome, Biotechnology


Last highlighted: #MCRB SEC report: Seres Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Seres Therapeutics, Inc. -- SEC File Number 211137957
+ My List
NRIX Nurix Therapeutics, Inc. - Common stock 6.06% down 8.27% -2.21 + Biotechnology, Cancer fight, Immunology


Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020
+ My List
NTLA Intellia Therapeutics, Inc. - Common Stock -6.26% up -7.23% 0.97 + Medicine, Gene and cell, Biotechnology, Biopharma

+ My List
OMER Omeros Corporation - Common Stock 0.88% down 8.34% -7.46 + Biopharma, Biotechnology, Medicine


Last highlighted: #OMER SEC report: OMEROS CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by OMEROS CORP -- SEC File Number
+ My List
ONCR Oncorus, Inc. - Common Stock -8.47% down -7.81% -0.66 + Cancer fight, Immunology, Biotechnology


Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316
+ My List
ORGS Orgenesis Inc. - Common Stock -0.2% up -7% 6.8 + Biotechnology, Medicine, Gene and cell


Last highlighted: Filing Alert, FORM 10-Q [Quarterly Report] available. $ORGS #Orgenesis Inc. Orgenesis Inc https://t.co/cwDFhLgUnk
+ My List
PDSB PDS Biotechnology Corporation - Common Stock 4.86% down 7.35% -2.49 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
+ My List
PRQR ProQR Therapeutics N.V. - Ordinary Shares 0.77% up -7.62% 8.39 + Medicine, Biotechnology, Disease: Eye , RNA

+ My List
QRVO Qorvo, Inc. - Common Stock -1.4% up -8.69% 7.29 + Semiconductor, Biotechnology, Diagnosing, IoT, 5G, Mobile, Network Infrastructure, Equipment

+ My List
RGNX REGENXBIO Inc. - Common Stock 2.88% down 9.63% -6.75 + Gene and cell, Biotechnology, Medicine

+ My List
RKDA Arcadia Biosciences, Inc. - Common Stock 7.02% up 6.58% 0.44 + Agritech, Biotechnology


Last highlighted: #RKDA SEC report: Arcadia Biosciences, Inc. [Amend] Current report, item 9.01
SEC Filing Form 8-K/A filed by Arcadia Biosciences, Inc. -- SEC File Number 211136758
+ My List
RLMD Relmada Therapeutics, Inc. - Common Stock 1.08% 1.08% 0 + Disease: Central nervous system (CNS), Biotechnology, Medicine


Last highlighted: $RLMD 📜 SEC Form 10-Q filed by Relmada Therapeutics, Inc. https://t.co/CGB5BcamVJ 30s delayed. This insight appeared in real-time at 🚆 https://t.co/TvhaBDQJ0C 🚆
+ My List
RVMD Revolution Medicines, Inc. - Common Stock 3.5% up -8.48% 11.98 + Cancer fight, Medicine, Biotechnology

+ My List
SELB Selecta Biosciences, Inc. - Common Stock 6.48% down 7.73% -1.25 + Biotechnology, Immunology, Biology, Medicine


Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS
+ My List
SLRX Salarius Pharmaceuticals, Inc. - Common Stock -0.97% -0.97% 0 + Cancer fight, Biotechnology, Medicine, Pharmaceutical


Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm) 📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock https://t.co/AWdEx2wgvD #SLRX #8K #SalariusPharmaceuticals #News
+ My List
SNES SenesTech, Inc. - Common Stock 1.22% up -8.89% 10.11 + Biotechnology, Agritech


Last highlighted: $SNES SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers https://t.co/6t4UWwGDlL
+ My List
TWST Twist Bioscience Corporation - Common Stock 15.56% 15.56% 0 + Biotechnology, RNA, Medicine


Last highlighted: #TWST SEC report: Twist Bioscience Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Twist Bioscience Corp -- SEC File Number
+ My List
WVE Wave Life Sciences Ltd. - Ordinary Shares 2.55% up -10.59% 13.14 + Medicine, Biotechnology, Life Sciences

+ My List
XOMA XOMA Corporation - Common Stock -12.53% up -12.57% 0.040000000000001 + Biotechnology, Medicine, Acquisitions/Investing

+ My List
YTEN Yield10 Bioscience, Inc. - Common Stock 3.11% down 8.73% -5.62 + Biotechnology, Agritech, Food

+ My List
AGFY Agrify Corporation - Common Stock 8.46% 8.46% 0 + Biotechnology, Cannabis, Farm, Agritech

+ My List
ENVB Enveric Biosciences, Inc. - Common Stock -10.24% down -4.78% -5.46 + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology


Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155
+ My List
EVAX Evaxion Biotech A/S - American Depositary Share -7.95% -7.95% 0 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology


Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935
+ My List
GBS GBS Inc. - Common Stock 6.45% down 8.5% -2.05 + Medicine, Biotechnology

+ My List
IDBA IDEX Biometrics ASA - American Depositary Shares -2.46% up -7.02% 4.56 + Technology, Security, Biotechnology, Fingerprint

+ My List
LGVN Longeveron Inc. - common stock -2.67% up -8% 5.33 + Biotechnology, Medicine, Gene and cell, Disease: Neurology/Alzheimer/Parkinson's

+ My List
LIXT Lixte Biotechnology Holdings, Inc. - Common Stock 1.78% up -7.41% 9.19 + Biotechnology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663
+ My List
RXDX Prometheus Biosciences, Inc. - Common Stock 7.7% down 8.02% -0.32 + Biotechnology, Medicine, Diagnosing, Immunology

+ My List
VRDN Viridian Therapeutics, Inc. - Common Stock 0.00% 0 + Disease: Eye , Medicine, Biotechnology


Last highlighted: $VRDN 8-K/A Viridian Therapeutics (15 Jun, 5:30pm) 📰 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (amendment) https://t.co/Ot2kOEW3mb #VRDN #8KA #ViridianTherapeutics #News
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.